Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has issued an announcement.
Adherium Ltd. has issued 135,095,871 fully paid ordinary shares and lodged a cleansing notice under section 708A(5)(e) of the Corporations Act 2001, confirming the shares were issued without a disclosure document. The company states it is compliant with its continuous disclosure and financial reporting obligations and that there is no excluded information requiring disclosure, positioning the new shares to be freely tradable on the ASX without further prospectus requirements.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Ltd. is an Australian digital health company and a global leader in connected respiratory medical devices, with more than 180,000 units sold worldwide. Its Hailie platform enables clinicians, healthcare providers and patients to remotely monitor respiratory medication use and adherence via integrated apps, APIs, SDKs and a broad range of connected sensors.
Technical Sentiment Signal: Sell
Current Market Cap: A$13.03M
For an in-depth examination of ADR stock, go to TipRanks’ Overview page.